Sample | Title | Value | Rank |
GSM125123 | 10A;pretreatment;female;breast tumor; responder | 3906.4 | 99 |
GSM125125 | 11A;pretreatment;female;breast tumor; nonresponder | 1676 | 97 |
GSM125127 | 12A;pretreatment;female;breast tumor; responder | 4908.1 | 99 |
GSM125129 | 13A;pretreatment;female;breast tumor; responder | 4217.8 | 99 |
GSM125131 | 14A;pretreatment;female;breast tumor; responder | 4541.4 | 99 |
GSM125133 | 15A;pretreatment;female;breast tumor; responder | 3030 | 98 |
GSM125135 | 16A;pretreatment;female;breast tumor; not assessable | 5862.9 | 99 |
GSM125137 | 17A;pretreatment;female;breast tumor; responder | 2008.9 | 97 |
GSM125139 | 18A;pretreatment;female;breast tumor; responder | 3597.2 | 98 |
GSM125141 | 19A;pretreatment;female;breast tumor; responder | 3510.4 | 99 |
GSM125143 | 20A;pretreatment;female;breast tumor; responder | 4712.1 | 99 |
GSM125145 | 21A;pretreatment;female;breast tumor; responder | 9696.4 | 99 |
GSM125147 | 22A;pretreatment;female;breast tumor; responder | 4233.6 | 99 |
GSM125149 | 23A;pretreatment;female;breast tumor; responder | 3977.6 | 99 |
GSM125151 | 24A;pretreatment;female;breast tumor; not assessable | 2550.1 | 98 |
GSM125153 | 25A;pretreatment;female;breast tumor; responder | 9388.1 | 99 |
GSM125155 | 27A;pretreatment;female;breast tumor; nonresponder | 1969.8 | 98 |
GSM125157 | 28A;pretreatment;female;breast tumor; responder | 2823.7 | 98 |
GSM125159 | 29A;pretreatment;female;breast tumor; responder | 1342 | 96 |
GSM125161 | 2A;pretreatment;female;breast tumor; responder | 822 | 93 |
GSM125163 | 30A;pretreatment;female;breast tumor; nonresponder | 5897.7 | 99 |
GSM125165 | 31A;pretreatment;female;breast tumor; responder | 2845.3 | 99 |
GSM125167 | 33A;pretreatment;female;breast tumor; nonresponder | 1708.7 | 98 |
GSM125169 | 34A;pretreatment;female;breast tumor; responder | 2001.6 | 98 |
GSM125171 | 35A;pretreatment;female;breast tumor; nonresponder | 9946 | 100 |
GSM125173 | 36A;pretreatment;female;breast tumor; nonresponder | 3621 | 99 |
GSM125175 | 37A;pretreatment;female;breast tumor; not assessable | 2058.6 | 98 |
GSM125177 | 38A;pretreatment;female;breast tumor; nonresponder | 5407.4 | 99 |
GSM125179 | 39A;pretreatment;female;breast tumor; responder | 4194.6 | 99 |
GSM125181 | 40A;pretreatment;female;breast tumor; responder | 1364.6 | 96 |
GSM125183 | 41A;pretreatment;female;breast tumor; responder | 3521.7 | 99 |
GSM125185 | 42A;pretreatment;female;breast tumor; nonresponder | 3403.2 | 99 |
GSM125187 | 44A;pretreatment;female;breast tumor; nonresponder | 3826.2 | 99 |
GSM125189 | 45A;pretreatment;female;breast tumor; responder | 5617.3 | 99 |
GSM125191 | 46A;pretreatment;female;breast tumor; not assessable | 4553.2 | 99 |
GSM125193 | 47A;pretreatment;female;breast tumor; responder | 1867.7 | 97 |
GSM125195 | 48A;pretreatment;female;breast tumor; responder | 4375.3 | 99 |
GSM125197 | 49A;pretreatment;female;breast tumor; responder | 4036.4 | 99 |
GSM125199 | 4A;pretreatment;female;breast tumor; not assessable | 2707.7 | 98 |
GSM125201 | 50A;pretreatment;female;breast tumor; responder | 3923.7 | 99 |
GSM125203 | 51A;pretreatment;female;breast tumor; responder | 3794.3 | 99 |
GSM125205 | 52A;pretreatment;female;breast tumor; nonresponder | 3491.5 | 99 |
GSM125207 | 53A;pretreatment;female;breast tumor; nonresponder | 3644.7 | 99 |
GSM125209 | 55A;pretreatment;female;breast tumor; responder | 2927.9 | 99 |
GSM125211 | 56A;pretreatment;female;breast tumor; not assessable | 1356.1 | 96 |
GSM125213 | 57A;pretreatment;female;breast tumor; responder | 2631.5 | 99 |
GSM125215 | 58A;pretreatment;female;breast tumor; responder | 2257.2 | 98 |
GSM125217 | 59A;pretreatment;female;breast tumor; nonresponder | 2319.3 | 98 |
GSM125219 | 5A;pretreatment;female;breast tumor; responder | 3547.8 | 99 |
GSM125221 | 60A;pretreatment;female;breast tumor; responder | 2788.2 | 98 |
GSM125223 | 63A;pretreatment;female;breast tumor; responder | 3759 | 99 |
GSM125225 | 64A;pretreatment;female;breast tumor; responder | 2823.6 | 99 |
GSM125227 | 65A;pretreatment;female;breast tumor; nonresponder | 6121 | 99 |
GSM125229 | 68A;pretreatment;female;breast tumor; nonresponder | 528 | 89 |
GSM125231 | 69A;pretreatment;female;breast tumor; responder | 7404.5 | 99 |
GSM125233 | 7A;pretreatment;female;breast tumor; responder | 4445.7 | 99 |
GSM125235 | 8A;pretreatment;female;breast tumor; nonresponder | 1302.3 | 96 |
GSM125237 | 9A;pretreatment;female;breast tumor; responder | 3969.3 | 99 |
GSM125124 | 10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 6325.9 | 99 |
GSM125126 | 11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 2044.1 | 97 |
GSM125128 | 12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 1514.2 | 96 |
GSM125130 | 13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 6494.3 | 99 |
GSM125132 | 14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3057.1 | 98 |
GSM125134 | 15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5785.9 | 99 |
GSM125136 | 16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable | 2808.5 | 98 |
GSM125138 | 17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 9967.2 | 99 |
GSM125140 | 18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5247.1 | 99 |
GSM125142 | 19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5747.7 | 99 |
GSM125144 | 20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 6142.2 | 99 |
GSM125146 | 21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 7366.1 | 99 |
GSM125148 | 22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4994.8 | 99 |
GSM125150 | 23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5823 | 99 |
GSM125152 | 24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable | 3186.8 | 98 |
GSM125154 | 25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 13161.9 | 99 |
GSM125156 | 27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 2138.9 | 98 |
GSM125158 | 28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4874.7 | 99 |
GSM125160 | 29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 2324.5 | 98 |
GSM125162 | 2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 865.4 | 94 |
GSM125164 | 30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 4105.3 | 99 |
GSM125166 | 31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4519.2 | 99 |
GSM125168 | 33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 3946.8 | 99 |
GSM125170 | 34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 6065.6 | 99 |
GSM125172 | 35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 9773.6 | 99 |
GSM125174 | 36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 7723.8 | 99 |
GSM125176 | 37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable | 4731.4 | 99 |
GSM125178 | 38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 3933.2 | 99 |
GSM125180 | 39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4737.2 | 99 |
GSM125182 | 40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 1726.4 | 97 |
GSM125184 | 41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4617.6 | 99 |
GSM125186 | 42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 3524.6 | 99 |
GSM125188 | 44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 1634.9 | 96 |
GSM125190 | 45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5210.9 | 99 |
GSM125192 | 46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable | 4558.9 | 99 |
GSM125194 | 47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 2999.8 | 98 |
GSM125196 | 48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3620 | 99 |
GSM125198 | 49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3897.5 | 99 |
GSM125200 | 4B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable | 4299.5 | 99 |
GSM125202 | 50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3844.2 | 99 |
GSM125204 | 51B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4872.1 | 99 |
GSM125206 | 52B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 3943 | 99 |
GSM125208 | 53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 2371 | 98 |
GSM125210 | 55B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4131.8 | 99 |
GSM125212 | 56B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable | 1439.6 | 96 |
GSM125214 | 57B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3709.7 | 99 |
GSM125216 | 58B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 4740 | 99 |
GSM125218 | 59B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 2316.1 | 98 |
GSM125220 | 5B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 2308.2 | 98 |
GSM125222 | 60B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 2585.4 | 98 |
GSM125224 | 63B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 7360.9 | 99 |
GSM125226 | 64B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3420.5 | 99 |
GSM125228 | 65B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 7049.9 | 99 |
GSM125230 | 68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 2242 | 98 |
GSM125232 | 69B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5096.3 | 99 |
GSM125234 | 7B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 5862.9 | 99 |
GSM125236 | 8B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder | 4323.6 | 99 |
GSM125238 | 9B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder | 3077.2 | 98 |